Thus, we conjectured that the mechanism of action of breast cancer regression upon Rlip depletion involved broad-spectrum effects on oncogenes and tumor suppressors that resembled those found in Rlip-null mice or p53-null mice with Rlip deficiency. The gene discussed is RALBP1; the disease is breast carcinoma.